About
Products
Knolens
KnolScapes
Knolens
Knolens SLR
Knolens
KnolQuest
Knolens
Edge
Knolens
DataNexus
Platform
Solutions
KnolSights
Experience Knolens
MeCo Score: A Novel Biomarker for Predicting Response to Antifibrotic Therapy in Breast Cancer
A multinational study published in the journal *Cancers* reveals that the MeCo Score, a novel biomarker, quantifies mechanical conditioning in breast ...
Copyright © 2025. All rights reserved
About
Terms of Service
Privacy Policy
Home/
KnloSights/
Clinical Trial Updates/
MeCo Score: A Novel Biomarker for Predicting Response to Antifibrotic Therapy in Breast Cancer